Skip to main content
Madura Tamhankar

Madura Tamhankar

Professor of Ophthalmology and Neurology at University of Pennsylvania; neuro-ophthalmologist specializing in thyroid eye disease, strabismus, and orbital disorders.

Jul 23, 2026

3:59
I did not realize that.
4:00
Yes.
4:00
And, uh, you know, what happened, fast-forward, this dogma, is that, you know, for the first eighteen months, when one gets diagnosed with TED, the patient is in an active phase where there is a lot of ongoing inflammation, and then in an eighteen months to two years timeframe, the inflammation subsides, and then cicatricial stage of the disease begins, and that's more stable, and th-that's the time that these patients should have surgery for either proptosis or double vision or eyelid procedures and so forth.
4:32
And, you know, in my medical school, in my ophthalmology residency, this is what I was taught.
4:38
But the reality was, aa-at, on the ground was so much different because I would see these patients come in and see me for years with disease flare-ups, and these disease flare-ups would happen the, after they, they had their eye surgeries.
4:53
So we were seeing these patients.
4:55
It's just that we j-didn't have a denominator.

6 MINS LATER

10:31
What did you find and what surprised you?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.